Entegris Sets ~15% Long-Term Revenue Growth Target, Authorizes $500 Million Buyback
Entegris targets 15% revenue CAGR, 30% adjusted EPS CAGR, and 55% adjusted gross margin long-term. The board authorized a $500M share buyback with no expiration. A 10% dividend increase is planned for Q1 2027, subject to approval. The company prioritizes growth, M&A, and returning cash to shareholders.
How this was made
The 30-second read
Why it matters
The announcement provides a fresh catalyst that could lift the stock as investors value the cash return and growth outlook.
Market read
First‑time disclosure of a sizable buyback and growth targets offers a clear, actionable signal for traders.
What to watch
Potential dilution from future equity issuances or execution risk on the 15% revenue CAGR target.
Background
Entigris filed an 8‑K on Nov 10 2026 outlining its long‑term financial targets and authorizing a $500 M share repurchase program.
Ticker impact
Entigris announced a $500 million share repurchase program and a 15% long‑term revenue CAGR target, new primary disclosure.
upward pressure as the market prices in the new buyback program
A $500 M repurchase is sizable for a mid‑cap and is the first report, providing a clear catalyst for short‑term buying.
Market effects
May boost sentiment in the specialty chemicals/materials sector as peers could face similar buyback expectations.
Positive for US-listed mid‑cap stocks, modest effect on broader market.
Limited to investors tracking US mid‑caps; no global macro impact.
Counterpoint
The buyback could be a defensive move masking slower organic growth, suggesting caution.
Key entities
- companyEntigris Inc.
US‑listed specialty chemicals and materials company (ticker ENTG).
